Direct Inhibition of Hepatitis B e Antigen by Core Protein Allosteric Modulator

Hepatitis B e antigen (HBeAg) is an important immunomodulator for promoting host immune tolerance during chronic hepatitis B (CHB) infection. In patients with CHB, HBeAg loss and seroconversion represent partial immune control of CHB infection and are regarded as valuable endpoints. However, the cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zhipeng, Wu, Daitze, Hu, Hui, Zeng, Jing, Yu, Xin, Xu, Zhiheng, Zhou, Zheng, Zhou, Xue, Yang, Guang, Young, John A.T., Gao, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618080/
https://www.ncbi.nlm.nih.gov/pubmed/30664279
http://dx.doi.org/10.1002/hep.30514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618080/
https://www.ncbi.nlm.nih.gov/pubmed/30664279
http://dx.doi.org/10.1002/hep.30514

Ejemplares similares